Loui, https://seekingalpha.com/symbol/LH/splits I sold on the reverse. I showed them my market knowledge. I think the price was something like $10.00 after the reverse. Sleven,
Agreed, but I would add that it also applies to CEOs of small bio companies - probably all companies.
I know that buyouts are figured out in market cap, but I agree that it is still hard to believe we could see $100 a share now after the RS. Some of us have gotten our cost averages down below that but we still need a very positive change in Amarin's business outlook to really get the stock price moving. The snail's pace of developments with Amarin (legal and business) makes it a race between rewards and death for me.